Non-interventional long-term follow-up observation of patients after successful catheter related blood stream infection (CRBSI) treatment with Geistlich TauroSept®

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026073

Enrollment

Registered

2021-08-17

Start date

2021-08-31

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection-free catheter instillation time after successful catheter infection treatment with Geistlich TauroSept® in a previous clinical investigation.

Interventions

Group 1: patients after successful infection treatment with Geistlich TauroSept®

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Written informed consent • Successful CRBSI treatment in the previous multicenter PMCF investigation • Final assessment of the previous PMCF investigation completed

Exclusion criteria

Exclusion criteria: • Newly diagnosed diseases/conditions affecting the functionality of the catheter/ needing catheter removal intervention • Severe trauma of the catheter site • Participation in a clinical investigation interfering with the objective of this non-interventional long-term follow-up observation • Use of catheter lock solution (CLS) containing taurolidine since the end of the Geistlich TauroSept treatment in the previous PMCF investigation

Design outcomes

Primary

Measure	Time frame
infection-free catheter instillation time	—

Secondary

Measure	Time frame
Different catheter complication parameters	—

Countries

Germany

Contacts

Public ContactDespoina Natsiou Schmiady

Geistlich Pharma AG

despoina.natsiou@geistlich.com+41 41492 6811

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026